Investor's Calendar

September 2023

Mon Tue Wed Thu Fri Sat Sun
28
29
30
31
1
2
3
 
 
 
 
 
 
 
4
5
6
7
8
9
10
 
 
 
 
 
 
 
11
12
13
14
15
16
17
 
 
 
 
 
 
 
18
19
20
21
22
23
24
 
 
 
 
 
 
 
25
26
27
28
29
30
1
 
 
 
 
 
 
 

Next Events

Last News

For the second year running, ROVI has obtained the best ranking in the pharmaceutical industry category in...
3 min
04 Aug, 2023
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the...
1 min
28 Jul, 2023
ROVI achieved stable total revenue of 381.0 million euros in the first post-pandemic half year
4 min
26 Jul, 2023

Information for investors

Marta Campos

Marta Campos

Head of Investor Relations

mcampos@rovi.es

Antonio Marquina

Antonio Marquina

Investor Relations

amarquina@rovi.es

buzón general Rovi

General Email